A-79/100

Is Arthur J. Gallagher & Co. (AJG) a risky stock?

Sector: Financials Price: $249.61 Composite: 79/100

As of July 21, 2026, Clavix grades Arthur J. Gallagher & Co. (AJG) A- for risk, a composite score of 79 out of 100 on an A+ to F scale, which puts AJG in the "solid" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind AJG's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how AJG scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
67
News sentimentscored, sourced recent coverage
65
Macro exposuresensitivity to rates, dollar, oil
77
Sector resiliencestrength vs the broad market
72
Price stabilitydrawdown and volatility
47

What's moving AJG's risk right now

Company-specific signals Clavix flags behind AJG's current grade, drawn from recent news and filings as of July 21, 2026.

Competition · raising risk

RBC says US property insurance prices may fall in Q2, which could squeeze commission revenue and organic growth at major brokerage AJG.

Execution · supporting the grade

AJG bought Kansas-based MGA Med James to expand its Midwest wholesale brokerage, and hired Michael Cipolla as VP of facultative to strengthen Gallagher Re's reinsurance team.

Competition · mixed signal

Nineteen brokerages give AJG an average 'Moderate Buy' rating, while competitor Brown & Brown trades at a discount due to higher expenses, debt load, and international exposure.

What a A- grade means

On the Clavix A+ to F scale, AJG's composite of 79 falls in the B band (65–79), read as "solid." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell AJG or any security. Grades are risk indicators, not predictions of return. Data may be delayed.